Lung Cancers Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00456716Sorafenib in BAC or Never-Smokers With Lung AdenocarcinomaTreatment
NCT00411671BATTLE Program: Sorafenib in Patients With NSCLCTreatment
NCT00064350Sorafenib in Treating Patients With Refractory Non-Small Cell Lung CancerTreatment
NCT00454194Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment